Search - tctmd.com

Displaying 1 - 20 of 24

Sort: Relevancy | Date

News Daily News

Stopping Tirzepatide Leads to Rebound in Weight, Cardiometabolic Risk

Todd Neale

December 12, 2023

News Daily News

Bempedoic Acid Reassures in Patients With and Without Diabetes: CLEAR Outcomes

Michael O'Riordan

December 08, 2023

News Conference News AHA 2023

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

Michael O'Riordan

November 11, 2023

News Daily News

FDA Grants Tirzepatide a New Indication for Obesity Management

L.A. McKeown

November 08, 2023

News Daily News

Very High LDL Cholesterol Declines in US Adults, but Progress Is Slow

Michael O'Riordan

November 02, 2023

News Conference News HFSA 2023

Semaglutide Works Across LVEF Range: STEP-HFpEF Analysis

Todd Neale

October 11, 2023

News Opinion CV Team Dispatch

October 2023 News Roundup

L.A. McKeown

October 01, 2023

News Daily News

PET-Guided Strategy Lowers Risk, Boosts Outcomes in Stable CAD: CENTURY

Michael O'Riordan

September 29, 2023

News Daily News

European Regulators Investigating CV Safety of Weight-Loss Drug Mysimba

Michael O'Riordan

September 15, 2023

News Daily News

Mortality, CVD Benefits Seen at Relatively Low Daily Step Counts

Michael O'Riordan

September 08, 2023

News Conference News ESC 2023

More Details on Acoramidis’ Benefit in ATTR Cardiomyopathy: ATTRibute-CM

Michael O'Riordan

August 31, 2023

News Daily News

SELECT: Semaglutide Cuts CV Events in Adults With Overweight or Obesity

Todd Neale

August 08, 2023

News Daily News

CVD Risk Reduction With Exercise Also Seen in ‘Weekend Warriors’

Michael O'Riordan

July 24, 2023

News Daily News

New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization

Michael O'Riordan

July 20, 2023

News CV Team Pro

Viet Le

L.A. McKeown

July 07, 2023

News Daily News

AHA Scientific Statement Addresses Health Disparities in PAD

L.A. McKeown

June 23, 2023

News Daily News

New Expert Consensus Papers Aim to Boost Management, Outcomes in HFpEF

L.A. McKeown

April 19, 2023

News Daily News

Moderate-Intensity Exercise Possible For Patients With Statin Side Effects

Michael O'Riordan

April 03, 2023

News Opinion CV Team Dispatch

April 2023 News Roundup

L.A. McKeown

April 01, 2023

News Conference News ACC 2023

Diabetic Patients in Middle East, Africa Overburdened by ASCVD

Michael O'Riordan

March 14, 2023

Advertisement

Stopping Tirzepatide Leads to Rebound in Weight, Cardiometabolic Risk

Bempedoic Acid Reassures in Patients With and Without Diabetes: CLEAR Outcomes

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

FDA Grants Tirzepatide a New Indication for Obesity Management

Very High LDL Cholesterol Declines in US Adults, but Progress Is Slow

Semaglutide Works Across LVEF Range: STEP-HFpEF Analysis

October 2023 News Roundup

PET-Guided Strategy Lowers Risk, Boosts Outcomes in Stable CAD: CENTURY

European Regulators Investigating CV Safety of Weight-Loss Drug Mysimba

Mortality, CVD Benefits Seen at Relatively Low Daily Step Counts

More Details on Acoramidis’ Benefit in ATTR Cardiomyopathy: ATTRibute-CM

SELECT: Semaglutide Cuts CV Events in Adults With Overweight or Obesity

CVD Risk Reduction With Exercise Also Seen in ‘Weekend Warriors’

New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization

Viet Le

AHA Scientific Statement Addresses Health Disparities in PAD

New Expert Consensus Papers Aim to Boost Management, Outcomes in HFpEF

Moderate-Intensity Exercise Possible For Patients With Statin Side Effects

April 2023 News Roundup

Diabetic Patients in Middle East, Africa Overburdened by ASCVD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content